Mohammad S. Email & Phone Number

Chicago, IL, US

Thousand Oaks, CA, US

Accountable for leading the commercial team in maximizing the value of KRYSTEXXA, an infused biologic for uncontrolled gout rare disease patients, providing strategic direction in the Phase IV program as the commercial lead

Dublin, Ireland, IE

• Served as a pre-launch commercial product strategic lead focused on UPLIZNA lifecycle management indications. Provide strategic direction and lead the pre-launch commercial activities and long-term therapeutic area.
• Developed an over-arching strategic platform for UPLIZNA across NMOSD, gMG, and IgG4-RD indications
• Led the pre-launch commercial planning and development for healthcare providers and hospitals for UPLIZNA generalized Myasthenia Gravis (gMG) and IgG4-RD indications; manage the commercial strategy development for the.
• Integrated innovation into daily workflows, utilizing AI and machine-learning algorithms to locate new U.S. patients
• Oversaw the performance and production of a cross-functional team of 18
• Built and maintained strong relationships with four vendors; determine the agreement terms and rates for success

Valby, Copenhagen, DK

• Developed and managed the vision, strategy, leadership, and commercial input in molecules from PI through PIII clinical trials; supported the research and evaluation activities globally for pre-clinical and in-market.
• Led the commercial valuation for Viela Bio, including the UPLIZNA business development opportunity; collaborated, challenged, and assured sound financial forecasting aligned with the U.S. market throughout the.
• Managed the global business development initiatives for the company; guided the strategies for indication selections and commercial paths to market all Psychiatry/Neurology pipeline assets per project across governance.
• Oversaw the development of biosimilar loss of exclusivity (LOE) strategy for the company’s leading biologic compound

Valby, Copenhagen, DK

• Led the advancement of a compelling long-term global brand strategy; shaped and maintained a winning CNS portfolio, establishing Lundbeck as an enduring leader in the CNS area.
• Supervised, coached, and developed a team of 6+ multi-national brand managers throughout the managerial tenure
• Led the evolution of the post-launch Trintellix strategy, incorporating market and consumer insights by leading a cross-functional team of medical, market access, and medical affairs; increased market share from 1.2%.
• Launched and implemented a new brand strategy across Europe, China, Middle East, Latin and North American affiliates
• Led the lifecycle development plans for Trintellix as a commercial asset lead, inclusive of the Phase IV program, by leading cross-functional commercial and group project teams; presented the Phase IV clinical studies.
• Managed the global Trintellix profit and loss within 1% of the targeted plan

Valby, Copenhagen, DK

• Built and managed a motivated, talented, and high-performing team. Collaborated with the company’s seven global marketing counterparts and multiple cross-functional teams to drive the company’s strategy and vision.
• Hired, developed, and coached two product managers and led a three-product manager team
• Owned the annual brand strategy and tactical planning, including the 5-year budget and forecast plans and presenting to senior management
• Led the lifecycle management program with the alliance partner and conducted a robust assessment of potential opportunities to support Trintellix growth strategy
• Led the Joint Commercial Team’s annual planning process, including potential new indication consideration

Valby, Copenhagen, DK

• Led a comprehensive disease state pre-launch initiative. Developed and led non-personal promotion efforts directed at psychiatry, primary care, and NP/PA specialties. Maintained active engagement and partnership with.
• Promoted from Product Manager
• Developed and launched the sales strategy for a novel new antidepressant, Trintellix, with an alliance partner and global brand team in the U.S. market with successfully exceeding global peak sales to $1.5B
• Planned and executed the evolution of messaging and creative development for sales strategies post-launch, including physician adoption strategy and efforts

Lyngby, Denmark, DK

• Evaluated several mid-to-late-stage molecules in pain management and neurology
• In final discussions in acquiring a molecule to treat chronic pain
• Met with venture capitalists, angle investors and small investment groups to raise funding

Deerfield, IL, US

• Held profit and loss for the Walgreens Specialty Pharmacy department
• Assisted market research and help design studies that assess outcomes toward Specialty Pharmacy awareness

Basel, Baselstadt, CH

• Coached and mentored a marketing team of two product managers; developed brand strategies and campaigns to meet and exceed target goals
• Led advisory boards and KOL identification/development to provide feedback on promotional plans and peer-to-peer education; expanded reach to Nurse Practitioners/Physician Assistant markets to optimize product adoption

Secaucus, NJ, US

• Launched AccuTypeTMCP assay for early identification of patients who are predisposed to poor Plavix(TM) therapy response
• Retained over $12 million in product sales for Vitamin D assay by leading targeted sales communication to key accounts

San Francisco, California, US

• Provided pro bono consulting services to non-profit organizations in areas such as brand management, strategic planning, and marketing campaigns.

Abbott Park, Illinois, US

• Retained over $54 million in product sales by leading eight employees in a Florida-based targeted communications initiative after the loss of negative formulary status

Abbott Park, Illinois, US

• Recruited and supervised 15 employees in an e-sales aid pilot, achieving a reduction of promotional printing costs by 32% and an increase in product sales by 12%

Abbott Park, Illinois, US

• Achieved a 2% market share increase for Synthroid by cultivating brand loyalty via patient educational brochures, tear pads, and prescription carriers

Abbott Park, Illinois, US

• Acted as a liaison between marketing, medical, regulatory, legal, compliance, and purchasing divisions for products generating over one billion in sales.
• Launched Depakote-ER by managing over 20 projects within aggressive timelines for direct-to-consumer and promotional materials

Abbott Park, Illinois, US

• Maintained top 5% market share in the nation; Increased market share from 14.8% to 15.4% in one month by focusing promotion efforts on the top 10% of prescribing physicians

Abbott Park, Illinois, US

• Wrote process validation protocols for 40 products to assist in removing FDA consent decree in ADD manufacturing

US

• Managed tissue culture and molecular biology laboratory in the Oncology Department of Loyola University

Master Of Business Administration - Mba

Bachelor Of Science - Bs, Biology, Minor In Chemistry